January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

April 22, 2015

If you were impressed by the recent switches of Nasacort Allergy 24HR, Nexium 24HR or Flonase — well-executed and model switches — well, you ain’t seen nothing yet.

April 21, 2015

The personal care products industry supports legislation introduced Monday that would bring greater FDA oversight. 

April 16, 2015

According to the Food and Drug Administration, heart failure is a common condition that affects close to 5.1 million people in the United States. The condition arises when the heart cannot pump enough blood to meet the body’s needs. 

April 7, 2015

A new indication for Boehringer Ingelheim Pharmaceuticals's Pradaxa may be on the horizon. 

April 7, 2015

Mylan on Tuesday announced the launch of norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets, 75 mg (chewable).

April 6, 2015

The Independent Pharmacy Alliance endorses ImmuDyne's full line of INR Wellness immune support products. 

April 2, 2015

Sam's Club on Thursday sweetened the pot for its Plus and Business Plus members with an offering of five generic prescriptions without charge in most states. 

March 31, 2015

The drug is Food and Drug Administration-approved to treat opioid-induced constipation in adults with chronic, non-cancer pain. 

March 31, 2015

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

March 11, 2015

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

March 11, 2015

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

March 10, 2015

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

March 4, 2015

Almost half of all circular ads in support of a digestive remedy promote an antacid tablet. 

March 4, 2015

Drug Store News has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports. This edition explores cold/allergy/sinus products in both the liquid/powder and tablets/packets segments.

March 4, 2015

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

February 25, 2015

GlaxoSmithKline's Alli weight loss aid is making a return to shelves.

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday.